Our laboratory played a major role in deriving the laboratory data and in coordinating the cooperative effort that led to the successful uses of single collections of human umbilical cord blood, as an alternative to adult bone marrow, for provision of HLA-matched allogeneic sibling stem/progenitor cells in 3 children with Fanconi anemia. This grant application is a joint effort to evaluate hematologically and immunologically the hypothesis that cord blood cells have a broader basis for use in other disorders currently treated with bone marrow, including adults as well as children. We propose to: 1) measure total hematopoietic stem/progenitor cells in human umbilical cord blood collections by, a) in vitro methodologies with new and currently used growth factors and modified culture conditions to enhance detection of early hematopoietic and more lineage restricted cells, and b) in vivo using immunodeficient (SCID, bg/nu/xid) mice as recipients for human hematopoietic repopulating cells, 2) expand cord blood stem/progenitor cells using various cytokines that can stimulate, enhance, or suppress various stages of their production, as assessed by the above in vitro and in vivo assays, 3) investigate the quantitative and qualitative expression of polymorphic antigens on the progenitors using allo-antibodies to HLA-class I and class II antigens, modulation of these antigens, and susceptibility of progenitors to antigen-specific lysis or growth inhibition by cloned cytotoxic T-lymphocytes against major- and minor-histocompatibility antigens, 4) investigate reactivity of these cells to certain allo-antigens, especially, the cytotoxic T-lymphocyte precursor cell frequency directed against several polymorphic antigens against various related and unrelated individuals, and 5) investigate whether cord blood cells exhibit an antileukemic reactivity against leukemic cells and clonogenic leukemic precursor cells. Adult bone marrow will be comparatively analyzed in the above 5 aims. These studies will provide information on numbers of stem/progenitors in single collections, expansion of such cells in vitro, whether such cells have decreased immunological reactivity allowing them to be used to advantage in situations with reduced graft verses host disease, perhaps in haplo-identical transplants, but with maintenance of antileukemic cell reactivity.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL046549-04
Application #
2223039
Study Section
Special Emphasis Panel (SRC (JD))
Project Start
1991-05-01
Project End
1995-02-28
Budget Start
1994-03-01
Budget End
1995-02-28
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005436803
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Tauchi, T; Miyazawa, K; Feng, G S et al. (1997) A coiled-coil tetramerization domain of BCR-ABL is essential for the interactions of SH2-containing signal transduction molecules. J Biol Chem 272:1389-94
Xiao, M; Li, Z H; McMahel, J et al. (1996) Inhibitory effects of interleukin 12 on retroviral gene transduction into CD34 cord blood myeloid progenitors mediated by induction of tumor necrosis factor-alpha. J Hematother 5:171-7
Lu, L; Ge, Y; Li, Z H et al. (1996) Retroviral transfer of the recombinant human erythropoietin receptor gene into single hematopoietic stem/progenitor cells from human cord blood increases the number of erythropoietin-dependent erythroid colonies. Blood 87:525-34
Xiao, M; Yang, Y C; Yang, L et al. (1996) Transduction of human interleukin-9 receptor gene into human cord blood erythroid progenitors increases the number of erythropoietin-dependent erythroid colonies. Bone Marrow Transplant 18:1103-9
Shen, R N; Lu, L; Kaiser, H E et al. (1996) Curative effect of split low dosage total-body irradiation on murine AIDS induced by Friend virus: the results and the possible mechanism. In Vivo 10:191-9
Horie, M; Sakamoto, K M; Broxmeyer, H E (1996) Regulation of egr-1 gene expression by retinoic acid in a human growth factor-dependent cell line. Int J Hematol 63:303-9
Takahira, H; Lyman, S D; Broxmeyer, H E (1996) Flt3 ligand prolongs survival of CD34++ + human umbilical cord blood myeloid progenitors in serum-depleted culture medium. Ann Hematol 72:131-5
Broxmeyer, H E (1996) Primitive hematopoietic stem and progenitor cells in human umbilical cord blood: an alternative source of transplantable cells. Cancer Treat Res 84:139-48
Lisovsky, M; Braun, S E; Ge, Y et al. (1996) Flt3-ligand production by human bone marrow stromal cells. Leukemia 10:1012-8
Broxmeyer, H E; Cooper, S; Li, Z H et al. (1996) Macrophage-stimulating protein, a ligand for the RON receptor protein tyrosine kinase, suppresses myeloid progenitor cell proliferation and synergizes with vascular endothelial cell growth factor and members of the chemokine family. Ann Hematol 73:1-9

Showing the most recent 10 out of 89 publications